The interaction of Ras with GTPase-activating proteins  by Wittinghofer, Alfred et al.
FEBS 18466 FEBS Letters 410(1997) 63-67 
Minireview 
The interaction of Ras with GTPase-activating proteins 
Alfred Wittinghofer *, Klaus Scheffzek, Mohammad Reza Ahmadian 
Max-Planck-Institut fur molekulare Physiologie, Rheinlanddamm 201, 44139 Dortmund, Germany 
Received 11 March 1997 
Abstract Ras plays a major role as a molecular switch in many 
signal transduction pathways which lead to cell growth and 
differentiation. The GTPase reaction of Ras is of central 
importance in the function of the switch since it terminates 
Ras-effector interactions. GTPase-activating proteins (GAPs) 
accelerate the very slow intrinsic hydrolysis reaction of the GTP-
bound Ras by several orders of magnitude and thereby act as 
presumably negative regulators of Ras action. The GTP 
hydrolysis of oncogenic mutants of Ras remains unaltered. In 
this review we discuss recent biochemical and structural findings 
relating to the mechanism of GAP action, which strengthen the 
hypothesis that GAP accelerates the actual cleavage step by 
stabilizing the transition state of the phosphoryl transfer 
reaction. 
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1. The players 
Ras-related GTP-binding proteins are involved in a variety 
of cellular processes. They function as molecular switches and 
exist in an 'inactive' GDP-bound or an 'active' GTP-bound 
state. Their nucleotide occupancies are regulated by a variety 
of proteins including guanine-nucleotide exchange factors 
(GEFs), and GTPase-activatmg proteins (GAPs) [1,2]. GEFs 
promote the release of tightly bound GDP on the GTP-bind-
ing protein and thereby achieve loading with GTP. The GTP-
binding proteins return to the inactive state by virtue of the 
GTPase reaction, which is usually very slow but can be accel-
erated by the action of GAPs, in the case of the Ras/Ras-
GAPs and Ran/Ran-GAP interactions by several orders of 
magnitude [3-5]. 
The superfamily of Ras-related GTP-binding proteins con-
sists of several subfamilies such as the Ras, Rho/Rac, Rab, 
Arf and Ran subfamilies. These proteins have common se-
quence elements, and show the same overall three-dimensional 
fold as demonstrated by the structures of Ras [6,7], Rap [8], 
Arf [9,10], Ran [11], Racl [12] and Rab (P. Metcalf, unpub-
lished data). The structure very closely resembles the G-do-
main in other GTP-binding proteins such as EF-Tu [13,14] 
and the heterotrimeric G proteins transducin and Giocl 
[15,16]. In contrast to the GTP-binding proteins themselves, 
the GAPs specific for the various members of the Ras super-
family are not sequence related and contain a different set of 
invariant residues, although their structures look similar in 
Corresponding author. Fax: (49) (231) 1206230. 
E-mail: alfred.wittinghofer@mpi-dortmund.mpg.de 
that they are purely ct-helical [17-19]. For the discussion of 
the GTPase reaction and how it might be accelerated by GAP, 
we will focus on Ras itself in the present review. 
Five mammalian GAPs for Ras have been described. The 
first, pl20GAP, is the prototype of this class of proteins and 
was the first one to be isolated [20-22]. Apart from being a 
regulator of Ras, its N-terminal domain contains a number of 
signalling modules such as SH2, SH3, PH, Calb domains and 
is believed to be a signal transduction molecule that may act 
independently of Ras [23,24]. The second Ras-specific GAP is 
neurofibromin (NF1), which is the product of the neurofibro-
matosis gene [25] and has also been shown to stimulate the 
GTPase of Ras [26-28]. This gene has been found to be fre-
quently mutated in patients with the disease neurofibroma-
tosis type I [29-31] but also, albeit less frequently, in solid 
tumors [32]. GAPP", a mammalian homologue of the 
Drosophila GAP1 gene [33], has been described, and a close 
homologue GAPIII [34], both of which contain, in addition to 
the GRD (GAP-related domain), C2 domains and a PH do-
main. Recently an inositol-4-phosphate (IP4) binding protein 
GAP1 IP4BP has been purified, cloned, and found to contain a 
Ras-GAP catalytic domain. In contrast to the other GAP 
mentioned, which are specific for Ras, GAP1 IP4BP stimulates 
the GTPase of both Ras and Rap [35]. 
2. The chemical mechanism 
The mechanism by which GAPs accelerate the GTPase re-
action of Ras has been a matter of considerable debate [36]. 
This is particularly relevant since oncogenic Ras mutants con-
tribute to tumor formation in 25-30% of all cancer patients, 
and the molecular defect in these proteins is the inability of 
mutant Ras to hydrolyze GTP. Furthermore and more impor-
tantly, the GTPase reaction cannot be stimulated by GAP. 
Therefore in the case of Ras we have one of the most signifi-
cant relations between a biochemical defect of a protein and a 
pathological disorder. This makes the elucidation of the chem-
ical mechanism of the GTPase and of its catalysis by GAP 
even more intriguing. 
Contrary to phosphoryl transfer in solution it is generally 
believed that in enzymes the reaction proceeds as an associa-
tive in-line transfer of the phosphate group with a pentavalent 
intermediate and an inversion of configuration of stereochem-
istry. For the intrinsic (non-GAP-catalyzed) GTPase of Ras 
inversion of configuration has been demonstrated using a de-
rivative of GTP which contains a chiral y-phosphate [37]. 
Furthermore it has been found that activation of the nucleo-
philic water is achieved by the y-phosphate of GTP itself act-
ing as a general (or specific) base [38,39]. Other interpretations 
of the available data favoring a dissociative mechanism have 
also been put forward [40]. Further insight into the mecha-
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Fig. 1. Minimal scheme for the GTPase reaction of Ras with a hypothetical isomerization reaction preceding GTP hydrolysis. The binding of 
GTP is very fast and the affinity to GTP very high such that the protein is always saturated with nucleotide (GDP or GTP). GTP hydrolysis 
and release of inorganic phosphate have so far not been shown to be reversible reactions. Which of the individual reaction steps is rate-limiting 
and thus catalyzed by GAP is discussed in the text. 
nism is expected from the structural analysis of the Ras/Ras-
GAP complex, which is ongoing. 
3. The biochemistry 
So far only pl20GAP and neurofibromin have been inves-
tigated in detail, and they can be distinguished with respect to 
their catalytic properties [3,26,41]. Under saturating condi-
tions of pl20GAP, the kCBX of the GTPase reaction of Ras 
is 19 s_1, which means that the reaction is stimulated more 
than 105-fold, with a KD of 9.7 uM for the GAP/Ras-GTP 
interaction [3]. The GAP activity of GAP-334, a fragment of 
GAP which contains the catalytic domain, is slightly lower 
and has a slightly higher KB [4,42]. The catalytic fragment 
of neurofibromin, NF1-333, has a similar &cat (5-10 s
_1) 
but a much higher affinity than GAP-334 (KD of 0.1-0.3 
|0.M) [4,41,42]. No apparent difference in GAP activity was 
found between the catalytic fragment and full-length neuro-
fibromin [43,44]. Both Ras-GAPs work apparently equally 
well with K-, N- and H-ras [42]. The difference in affinity 
between GAP-334 and NF1-333 is due to a small difference 
in the association and a very large difference in the dissocia-
tion rate constants, and it is not entirely clear whether these 
differences reflect the different biological roles of the different 
GAPs [42]. 
Certain phospholipids and their breakdown products such 
as arachidonic acid were found to modulate GAP activity and 
the biological relevance of these observations is controversial 
[45,46]. The differential sensitivity of neurofibromin and 
pl20GAP towards lipids has, however, been used to quantify 
the GAP activity of the respective proteins in crude cell ex-
tracts [43,47]. For both GAPs, the KD for Ras-GTP is very 
sensitive towards salts with a doubling of Kn with the addi-
tion of 25 mM salts [4]. Interestingly, for NF1-333 the £cat 
increases with increasing ionic strength, being 27 s_1 at 
200 mM NaCl under saturating conditions of GAP [4]. The 
highest GTPase reaction rate can be measured by replace-
ment of Mg2+ by Mn2+, which increases both the intrinsic 
and the GAP-catalyzed reaction, the latter to a value of 
155 s_1 [48]. 
4. GAP and the transition state 
GAP catalyzes the overall reaction by several orders of 
magnitude, but which of the individual steps of the minimal 
scheme show in Fig. 1 is catalyzed has been at the center of 
the discussion. It has been argued that Ras itself is an efficient 
GTPase machine and that GAP favors the attainment of a 
conformation competent for a fast GTPase by catalyzing a 
rate-limiting isomerization reaction. Evidence for such an iso-
merization reaction in Ras has been presented by fluorescence 
spectroscopy whereby a fluorescent analogue of the non-hy-
drolyzable GTP analogue GppNHp showed a similar fluores-
cence change within a similar time range as the fluorescent 
GTP itself [49]. Since this was believed to represent a confor-
mational change preceding GTP hydrolysis and was appar-
ently rate-limiting, it was asked whether this fluorescent 
change is catalyzed by GAP in the same way as the chemical 
cleavage step. Conflicting evidence has been found to prove or 
disprove such a conclusion [42,50,51]. In another model for 
GAP action, the actual chemical cleavage step itself and not 
an isomerization preceding hydrolysis is influenced by GAP, 
the idea being that GAP contributes to creating and stabiliz-
ing the transition state of the reaction. In the most pro-
nounced form of the model, the arginine-finger hypothesis, 
GAP supplies residues into the active site of Ras to favor 
GTP hydrolysis. This model has recently gained much support 
from biochemical studies involving aluminum fluoride com-
plexes [52] and from the X-ray structure analysis of the cata-
lytic domain of pl20GAP [17]. It has also been shown that the 
release of Pi is not rate-limiting either in the intrinsic [53] or in 
the GAP-catalyzed reaction [54]. 
GTP hydrolysis by the a-subunit of heterotrimeric G pro-
teins is usually a hundred times faster than hydrolysis by Ras 
[1,2]. Structural studies have shown that the active sites of 
transducin and Gial resemble very much those of Ras, with 
the conserved sequence elements of GTP-binding proteins in-
volved in the binding of either the base, the ribose and the 
phosphates and Mg2+ ion. Compared to Ras-related proteins, 
the active site of Goc proteins contains an arginine that is 
invariant and is close to the phosphates in the triphosphate 
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Fig. 2. Ribbon plot (drawn with MOLSCRIPT, see ref. [60]) of the structure of a catalytic fragment of pl20GAP. It shows the position of the 
invariant and highly conserved residues as black and gray dots, respectively. The invariant arginines, one or both of which are believed to par-
ticipate in the GTPase reaction, are shown as ball and stick models. 
structures [15,16]. This arginine has been shown to be impor-
tant for GTP hydrolysis since it is found mutated in oncogenic 
versions of Ga proteins with impaired GTPase and is the 
target of ADP-ribosylation by cholera toxin from Vibrio cho-
lera, which reduces the GTPase reaction rate. All Ga proteins 
in the GDP-bound form, in contrast to Ras and other Ras-
related proteins [52,55], bind A1F^ ~ into the y-phosphate bind-
ing pocket and thereby stimulate the actions of Ga proteins in 
their GTP-bound state. The structures of Ga proteins in the 
presence of GDP and AlF^" have shown that AlFy mimics the 
transition state of the reaction by forming an octahedral ar-
rangement, where the A1F^ ~ forms the planar base and the 
oxygens from GDP (the leaving group) and the attacking 
water (the incoming group) occupy the apical positions of 
the octahedron [16,56]. This arrangement is believed to mimic 
the real pentavalent intermediate (or transition state) of the 
GTPase reaction. The transition state mimic is additionally 
stabilized by a glutamine, which in contrast to the arginine 
is conserved between Ras-related and Ga proteins. 
As stated above, Ras and the Ras-related proteins do not 
bind A1F^~. Following suggestions [2,57] that Ga proteins 
have an in-built GAP, whereas Ras-related proteins have a 
fraro-acting GAP, it was found that Ras'GDP also binds 
A1F^~, but only in the presence of stoichiometric amounts of 
Ras-GAP. In the absence of AlF^, GAP does not bind to 
Ras-GDP [52]. Oncogenic mutants of Ras such as 
Ras(G12V), which binds to GAP but is unable to hydrolyze 
GTP, do not bind AlF^ in the presence of GAP. Since, in 
analogy to Ga proteins,AlF^ in the presence of GDP is be-
lieved to mimic the transition state, and since stoichiometric 
amounts are needed for this effect, it can be argued that the 
role of GAP is unlikely to be that of a catalyst that catalyzes a 
conformational change on Ras but rather that it participates 
in the reaction. This is further strengthened by the finding that 
a GAP with a mutation of the invariant arginine, analogous 
to R903 in Fig. 2, binds to Ras'GTP and forms the ground 
state complex, but does not catalyze GTP hydrolysis or form 
the transition state mimic [52,58]. 
5. The Ras-GAP structure 
Originally, a 483-residue GAP-related domain (GRD) of 
neurofibromin had been described to contain full Ras-GAP 
activity [26,27]. Smaller fragments of 333-343 residues were 
also shown to possess full or almost full Ras-GAP activity 
[3,4]. The smallest fragment that is able to support full 
GTPase activating activity contains 230 residues from neuro-
fibromin and can be stably expressed and purified as a re-
combinant protein [59]. The three-dimensional structure of a 
catalytic fragment of the Ras-specific pl20GAP, GAP-334, 
has recently been determined [17]. The molecule is purely a-
helical (Fig. 2) and consists of two domains one of which 
corresponds to the minimal fragment from neurofibromin 
and is called the catalytic domain. It contains residues from 
the three blocks of sequence homology defined earlier and all 
the invariant residues. Most of the invariant residues are cen-
tered around a shallow groove in the middle on the molecule 
and are presumably oriented to interact with GAP. To have a 
first look at the complex between Ras and Ras-GAP, it was 
attempted to dock the two proteins together using as guideline 
66 
the numerous reports on the biochemical features of this en-
counter. It was thus found that the two invariant arginines, 
one or both of which are involved in the chemical reaction 
step, are situated close to the y-phosphate of Ras-bound GTP. 
This supports the notion that also from a structural view the 
participation of residues from GAP in the GTPase reaction is 
indeed very likely. 
6. Conclusions 
From both the structural and biochemical analysis of the 
Ras-GAP interaction it becomes more and more evident that 
residues from GAP participate in the GTPase reaction of Ras. 
Current data support the arginine-fmger hypothesis whereby 
we expect arginines to be involved in the stabilization of the 
transition state. In both the associative and the dissociative 
mechanism of phosphoryl transfer there is a developing 
charge in the transition state that would need to be neutral-
ized in order to speed up the reaction. In the case of the 
associative mechanism it would be on the y-phosphate and 
in the dissociative case it would be on the leaving group, 
which is the p\y-bridging oxygen. Thus it will be crucial to 
determine the X-ray structure of the Ras/Ras-GAP complex 
to see if indeed an arginine residue projects its side chain into 
the active site to interact with oxygens on GTP. It will also be 
interesting to see why oncogenic mutants of Ras are not 
stimulated by GAP. In the case of the Gln61 mutants this is 
because Gin itself is involved in stabilization of the transition 
state, in analogy to the Ga proteins [16,56]. For mutants of 
residue Glyl2, for which there is no consistent explanation 
why any substitution at this position, even the minimal change 
to alanine, renders the protein resistant to stimulation by 
GAP. Finally one would hope that the structure of Ras/ 
Ras-GAP complex allows one to design molecules that are 
able to increase the GTPase reaction of wild type and mutant 
Ras and thereby use the GTPase reaction as an attractive 
target for the development of anti-Ras drugs. 
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